Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Organon & Co. (NY: OGN )

15.99 +0.71 (+4.68%)
Streaming Delayed Price Updated: 11:57 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Organon & Co.

< Previous 1 2 3 4 5 6 7 8 9 Next >
First Real-World Observational Study of the JADA® System, a Medical Device to Control Postpartum Hemorrhage (PPH), Published in ACOG’s Obstetrics & Gynecology
From Organon & Co.
Via Business Wire
3 Pharmaceutical Stocks That Are Too Cheap to Ignore
Viatris, GSK, and Organon are all trading at less than 7 times earnings. 
Via The Motley Fool
Stock Analysis: Organon & Co.
Organon & Co. sells its products to drug wholesalers, retailers, hospitals, pharmacies, clinics, government agencies, and other institutions worldwide. 
Via Talk Markets
Organon Bolsters Research & Development Expertise with Two Leadership Appointments
From Organon & Co.
Via Business Wire
Organon's Return On Capital Employed Insights
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
3 Undervalued Healthcare Stocks In 2023
These 3 undervalued healthcare stocks in 2023 are attractive today for their attractive valuations and total return potential. 
Via Talk Markets
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Organon Reports Results for the Second Quarter Ended June 30, 2023
From Organon & Co.
Via Business Wire
5 Value Stocks In The Healthcare Sector
Via Benzinga
Samsung Bioepis & Organon Announce Topline Results from Interchangeability Study of SB5 Humira Biosimilar
From Samsung Bioepis
Via GlobeNewswire
Organon's Earnings: A Preview
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Need an Extra $4,000 in Dividends Each Year? Invest $68,000 in These 3 Stocks.
These stocks can significantly bolster your income. 
Via The Motley Fool
Datadog, IQVIA, Organon And An Oilfield Services Giant Rolling Out An AI Platform: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Jason Snipe of Odyssey Capital Advisors said he likes IQVIA Holdings Inc. (NYSE: IQV) 
Via Benzinga
Organon To Report Second Quarter Results and Host Conference Call on August 8, 2023
From Organon & Co.
Via Business Wire
REPEAT/Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA™ (adalimumab-bwwd) in Multiple Presentations Consistent with Originator
From Organon
Via Business Wire
3 S&P 500 Stocks to Own for the Next 50 Years
These three S&P 500 companies all buy and hold stocks for the next 50 years or more because they operate in attractive industries. 
Via InvestorPlace
Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA™ (adalimumab-bwwd) in Multiple Presentations Consistent with Originator
From Organon & Co.
Via Business Wire
Want $5,000 in Annual Dividend Income? Invest in These 3 Stocks
These stocks are down more than 5% this year, and now may be a good time to add them to your portfolio. 
Via The Motley Fool
Organon Publishes FY2022 ESG Report Showcasing Progress Toward Global Sustainability Goals
From Organon & Co.
Via Business Wire
Check Out 3 Health Care Stocks With Over 4% Dividend Yields From Wall Street's Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
Organon and CAF, Development Bank of Latin America, Launch First-of-Its-Kind Collaboration to Increase Sustainable Financing in Women’s Health
From Organon & Co.
Via Business Wire
7 Stocks That Are Long Overdue for a Relief Rally
Here are seven stocks with the catalysts and fundamentals to support a sustained relief rally in this environment. 
Via InvestorPlace
Daily Stock Analysis: Organon & Co
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions. 
Via Talk Markets
Check Out 3 Health Care Stocks With Over 3% Dividend Yields From Wall Street's Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
Organon Reports Results for the First Quarter Ended March 31, 2023
From Organon & Co.
Via Business Wire
Organon To Report First Quarter and Host Conference Call on May 4, 2023
From Organon & Co.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.